Larvol Delta - BriaCell-Adds-NYU-Langone-Healths-Perlmutter-Cancer-Center-as-Clinical-Site-in-Pivotal-Phase-3-Breast-Cancer-Study

Bria-IMT (SV-BR-1-GM) - BriaCell

https://feeds.issuerdirect.com/news-release.html?newsid=7892615166394334&symbol=BCTX

May 7, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next